Why the study?
Over one third of cardiovascular surgical patients have diabetes mellitus, and chronic hyperglycemia increases their risk of adverse cardiovascular events and poor surgical outcomes.
Do anti-diabetic medications and perioperative glucose optimization improve cardiovascular outcomes and surgical mortality in cardiovascular surgical patients with diabetes mellitus?
Do anti-diabetic medications and perioperative glucose optimization improve cardiovascular outcomes and surgical mortality in cardiovascular surgical patients with diabetes mellitus?
Optimizing perioperative glucose levels and implementing dedicated diabetic teams are key to improving surgical outcomes in cardiovascular surgery patients with diabetes.
Dedicated teams and perioperative glucose optimization may improve diabetic cardiac-surgery outcomes; leaves open ADM-specific benefits beyond glycemia.
Chronic hyperglycemia is associated with poor cardiovascular surgical outcomes due to microvascular and macrovascular complications. This is a major concern as over one third of cardiovascular surgical patients have diabetes mellitus which greatly increases their risk of experiencing adverse cardiovascular events. A literature review was performed to identify articles discussing the effects of anti-diabetic medications (ADMs) on cardiovascular outcomes and surgical mortality and morbidity rates. Optimizing perioperative glucose levels remains a key factor in producing good surgical outcomes. In addition, recognizing gender differences, increasing patient satisfaction, and implementing dedicated diabetic teams all improve surgical mortality and morbidity rates in the diabetic population.
No takes yet. Share an insight, caveat, or question.
O’Neill et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: